Our results show that lower SPOP protein expression also has prominent impact in HCC progression, which implies that SPOP deregulation at protein level (posttranscriptional regulation) may serve as a molecular marker in HCC. The gene discussed is SPOP; the disease is hepatocellular carcinoma.